新氧上涨2.22%，报2.995美元/股，总市值2.98亿美元

Core Viewpoint - The company Xinyang (SY) has experienced a decline in revenue and net profit, indicating potential challenges in its financial performance moving forward [1]. Financial Performance - As of June 30, 2025, Xinyang's total revenue was 676 million RMB, representing a year-over-year decrease of 6.84% [1]. - The company's net profit attributable to shareholders was -69.177 million RMB, reflecting a significant year-over-year decline of 2909.0% [1]. Stock Performance - On December 17, Xinyang's stock price increased by 2.22%, reaching $2.995 per share, with a total trading volume of $278,300 and a market capitalization of $298 million [1]. Upcoming Events - Xinyang is scheduled to release its third-quarter financial report for the fiscal year 2025 on November 19, with the actual disclosure date subject to company announcements [1]. Company Overview - Xinyang International is focused on leveraging technology to assist women in enhancing their beauty and health, aiming to transform the opaque medical aesthetics market in China by providing transparent information and establishing a one-stop platform for quality services [1].